HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next segment on its CEO Corner, a platform ...

Anticipated updates on the company’s leukemia drug SLS009 did not land, dampening near-term catalyst momentum. ・Earlier studies showed SLS009 triggered leukemia cell death and remained active in ...

President Nikos Chritodoulides announced before Tuesday’s council of ministers meeting that he had asked the US government ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...

First public disclosure of the chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16-dependent Targeted Glue™ ...

Cancer remains one of the leading causes of death in the Philippines, with thousands of patients delaying or abandoning ...

Following her diagnosis in 2020, Tia Stokes went viral for dancing every day throughout her acute myeloid leukemia treatment.

Dagco added 451,240 shares, making Sellas its second-largest holding at 1.01% of portfolio weight. ・The stake increase comes ahead of AACR presentation of preclinical data on SLS009, Sellas’ CDK9 ...

New platform automates identity verification, background screening, and AML/KYC compliance with real-time AI risk ...

The BIS, often called the central bank for central banks, has been skeptical of stablecoin for years, even when the token is ...

Kura Oncology, Inc. remains a Buy, driven by ziftomenib's launch and promising combination trial data in AML. Learn more ...